Table: Towa Pharmaceutical -2021/22 parent results

TOWA PHARMACEUTICAL

13/05/2022 07:00

May 13 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            123.30          115.35                                
                 (+6.9 pct)      (+7.1 pct)                              
  Operating         18.74           19.94                                
                 (-6.0 pct)      (+19.2 pct)                             
  Recurring         22.49           18.63                                
                 (+20.7 pct)     (-14.1 pct)                             
  Net               16.32           13.65                                
                 (+19.5 pct)     (-10.5 pct)                             
  EPS            331.57 yen      277.39 yen                              
  EPS Diluted    324.22 yen      265.95 yen                              
  Ann Div         60.00 yen       44.00 yen      60.00 yen               
  -Q2 Div         27.00 yen       22.00 yen      30.00 yen               
  -Q4 Div         33.00 yen       22.00 yen      30.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T